Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Chaudhary, Jasmine
- Quality Assessment and Comparative Study of different Marketed Brands of Metformin
Abstract Views :166 |
PDF Views:0
Authors
Affiliations
1 MM College of Pharmacy, MM (Deemed to be University), Mullana (Ambala), Haryana, IN
1 MM College of Pharmacy, MM (Deemed to be University), Mullana (Ambala), Haryana, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 3 (2019), Pagination: 1357-1360Abstract
Metformin, chemically N,N-dimethylimidodicarbonimidic diamide belonging to biguanides class is an orally effective drug of choice for the treatment of Type 2 diabetes mellitus which basically acts by activating enzyme AMPK which further control carbohydrate metabolism by reducing intestinal glucose absorption, hepatic glucose production and escalating insulin sensitivity. Various generic brands of metformin are available in the market which makes it difficult to select which brand can be used and whether it will have the same efficacy as that of ethical brand, therefore, the present study has been designed to evaluate the quality control parameters of different selected brands of metformin. The results indicated that all the selected drugs (whether branded or generic) fulfilled the required specifications and thus can be used freely as a substitution of each other.Keywords
Metformin, Generic, Branded, Quality, Parameters.
References
- Kalo Z, Holtorf AP, Alfonso C R, Shen J, Ágh T, Inotai A, Brixner D. Need for multicriteria evaluation of generic drug policies. Value Health. 2015; 18 (2): 346-51.
- Chaudhary J, Singh V, Sharma P, Jain A. In-vitro quality assessment of different marketed brands of ofloxacin tablets. Der Pharma Chemica. 2018; 10(5): 65-68.
- Mehnaz A, Fabiha FA, Nazma AR, Mohiuddin AB. Comparative in vitro evaluation of some commercial brands of valsartan tablets marketed in Bangladesh. The Pharma Innovation Journal. 2018; 7(4): 1068-1072.
- Caudron JM, Ford N, Henkens M, Mace C, Kiddle MR, Pinel J. Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Trop Med Int Health. 2008; 13(8):1062-72.
- Patel KT, Chotai NP. Documentation and Records: Harmonized GMP Requirements. J Young Pharm. 2011; 3(2): 138-150.
- Jannath S, Nayeema I, Jahan N, Kanij ND. Comparative performance evaluation of different brands of ketorolac tromethamine (NSAID’S) Generic Tablets. Advancements Bioequiv Availab. 2018; 1(1): 1-5.
- Thakuri GS, Yadav KK, Chhetri RR. Comparative in-vitro analysis of different brands of paracetamol tablets available in Nepal. Journal of Coastal Life Medicine. 2016; 4(8): 645-648.
- Manimala M, Veerashekar J, Hariharasharan S and Praveenkumar M. Comparison and evaluation of freely supplied government and ethically marketed antihypertensive drug (Atenolol). Der Pharma Chemica. 2018; 10(2): 32-35.
- Das M, Choudhury S, Maity S, Hazra A, Pradhan T, Pal A, Roy RK. Generic versus branded medicines: An observational study among patients with chronic diseases attending a public hospital outpatient department. J Nat Sci Biol Med. 2017; 8(1): 26–31.
- Naveed S, Huma D, Jaweed L. Comparative study of four different brands of ranitidine available in Karachi. Mod Chem Appl. 2014; 2:125.
- Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med. 2002; 137: 25-33.
- Elango P, Ramesh, Shanmuganathan S. A comparative analysis of commercial metformin tablets. Indian Journal of Clinical Practice. 2014; 24(8): 1-8.
- Sachan AK, Kumar V, Gupta A. Comparative in-vitro evaluation of four different brands of metformin HCl available in Kanpur district, India. Der Pharmacia Lettre. 2016; 8(5): 419-424.
- Daharwal SJ , Rao SP, Singh VK, Dwivedi C, Singh VD. Comparative evaluation of marketed formulations of Metformin HCl available in India. Asian J. Research Chem. 2015; 8(7): 441-444.
- Lachman L, Liberman H, Kanig J. The theory and practice of Industrial Pharmacy. Varghese Publishing House, Mumbai, 1987, 3, 171-195, 293-345.